Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progressive osseous heteroplasia controlled by intravenous administration of pamidronate.

American journal of medical genetics. Part A - 15 Apr 2006

Hou Jia-Woei

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Density Conservation Agents
Share to Chromogranins
Share to Diphosphonates
Share to GTP-Binding Protein alpha Subunits, Gs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Injections, Intravenous

Share to Ossification, Heterotopic

Share to Skin Abnormalities

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 16532474
DOI: 10.1002/ajmg.a.31200

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Progressive osseous heteroplasia controlled by intravenous administration of pamidronate.PMID 16532474Read ↗

Progressive osseous heteroplasia caused by a mosaic GNAS mutation.Semantic proximity Read ↗

Alternative bisphosphonate targets and mechanisms of actionSemantic proximity Read ↗

Molecular mechanisms of action of bisphosphonatesSemantic proximity Read ↗

Fundamental principles affecting the outcomes of therapy for osseous lesions.Semantic proximity Read ↗

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.Semantic proximity Read ↗

Effect of bisphosphonates on the rapidly growing male murine skeleton.Semantic proximity Read ↗

Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.Semantic proximity Read ↗

Intravenous pamidronate in osteogenesis imperfecta type VII.Semantic proximity Read ↗

Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral modelSemantic proximity Read ↗

Intravenous pamidronate treatment in osteogenesis imperfecta.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.